Analyst consensus rating
Bio-Techne Analyst Rating: Hold
Direct answer
Bio-Techne's consensus rating is Hold.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $70.50.
Forecast evidence checked November 3, 2026.
Get free Bio-Techne email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $72.67
- Average price target
- $70.50
- High price target
- $73.00
- Low price target
- $50.00
- Low target gap
- -31.2%
- Target upside
- -3%
- High target gap
- +0.5%
- Target range width
- 31.6%
- Consensus rating
- Hold
- Analysts
- 10
- Evidence date
- November 3, 2026
- Valid through
- November 10, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Bio-Techne?
Bio-Techne has a verified Hold consensus. The same dataset has an average price target of $70.50.
How far are Bio-Techne's low and high targets from the recorded price?
The low target implies -31.2%, while the high target implies +0.5%.
How many analysts are included in Bio-Techne's consensus?
The verified consensus includes 10 analysts.
How is Bio-Techne's target upside or downside calculated?
The average target of $70.50 is divided by the recorded price of $72.67, then one is subtracted to produce -3%. This does not guarantee a future return.
When was Bio-Techne's analyst forecast verified?
The data was verified on 2026-11-03. The dataset is valid through 2026-11-10.